item management s discussion and analysis of financial condition and results of operations liquidity and capital resourcesthe company generated approximately  of cash from operations during the fiscal year ended march  the increase in funds generated comes from the increase in accounts payable and accrued expenses offset by an increase in the level of inventories and a decrease in deferred taxes 
during fiscal year  approximately  of cash was used by the company in its investing activities  principally the purchase of equipment and the buyout of the minority shareholder at vital scientific 
the sale of certain assets also provided funds for these investing activities 
financing activities were immaterial during the year ended march  in april  the company entered a new relationship with a major dutch bank  which provides for a  dutch guilder approximately  line of credit 
interest on this facility is set at above the base rate as reported by the netherlands central bank  presently 
trade receivables and inventory of vital scientific are provided as security for this facility 
the line continues as long as certain capital covenants are met 
the company s sources of cash include cash balances and the aforementioned  dutch guilder line of credit from a dutch bank 
the company believes that available funds will provide it with sufficient working capital through fiscal year results of operations fiscal year ended march  compared to fiscal year ended march  consolidated revenues for fiscal year were  versus  for fiscal year  a decrease of approximately 
the decline is principally due to the strengthening of the us dollar against the company s primary functional currency  the dutch guilder 
the gross margin improved from to from fiscal year to fiscal year the increase reflects improved material costs  cost containment and a change in the product mix 
sales and marketing expenses decreased  or from fiscal year a reduction in expenses was responsible for of the decline and the weakening of the dutch guilder against the us dollar accounted for the rest 
the decrease in expenses resulted from cost containment  reduced sales commissions and reduced technical service expenses 
research and development expenses  as shown on the consolidated statement of operations  increased  or from fiscal year during fiscal years and  the company spent an additional  and  respectively  in research and development which were capitalized onto the consolidated balance sheet pursuant to the precepts of statement of financial accounting standards no 
see note l n in the notes to consolidated financial statements 
when expressed in the company s primary functional currency  the dutch guilder  the spending on research and development was essentially constant for fiscal years and the decrease in the spending  when expressed in us dollars  is wholly attributable to the strengthening of the us dollar against the dutch guilder 
general and administrative expense in fiscal year decreased  or from fiscal year the expense increased when expressed in the company s functional currency  the weakening of the dutch guilder against the us dollar caused the decrease as reported 
the increased costs are primarily attributable to employee recruitment expenses  temporary contract personnel and one time consulting expenses 
interest expense increased primarily from expenses related to the credit financing grant received by vital scientific from the dutch government for new product development 
the grant is repaid from product sales with interest accruing on the unpaid balance 
shipments of the new product commenced in the fourth quarter of fiscal year interest income increased from invested funds 
other income and expense  as illustrated in note in the notes to consolidated financial statements  is largely comprised of the gain from the settlement with e 
merck and the gain on the sale of certain assets at vital scientific 
the remainder of the balance shows the effect of foreign currency transaction gains and losses on the results of operations 
as noted above  on october   vital scientific became a wholly owned subsidiary of the company 
the minority interest on the consolidated statement of operations reflects the of vital scientific s operations held by a minority shareholder until october  the effect of foreign currency transaction exchange on the results of operations is included in other income expense and is not material to the financial statements 
see note in notes to consolidated financial statements 
any impact on the company s liquidity is largely dependent on the exchange rates in effect at the time the company s predominant foreign functional currency  the dutch guilder  is translated into us dollars 
approximately  of the march  balance of  of cash and cash equivalents is denominated in us dollars 
the effect of translation into us dollars is reflected as a separate component of stockholders investment on the balance sheet 
the cumulative translation adjustment in stockholders investment is approximately three percent of total assets on the march  consolidated balance sheet 
the effects of currency exchange rates on future quarterly or fiscal periods on the results of operations are difficult to estimate 
there are no formal hedging procedures employed by the company 
the primary risk is to monetary assets and liabilities denominated in currencies other than the us dollar 
approximately million of million of current assets reside in the company s foreign subsidiaries 
fiscal year ended march  compared to fiscal year ended march  consolidated revenues for fiscal year were  versus  for fiscal year  a decrease of approximately twenty three percent 
the decline is principally due to the default of a major customer  e 
merck  on a series of agreements coupled with an eight percent strengthening of the company s primary functional currency  the dutch guilder  against the us dollar 
the gross margin decreased from for fiscal year to for fiscal year primarily because of a reduced absorption rate of manufacturing overhead expenses 
in addition  there was continued pricing pressure from a competitive market at vital scientific 
sales and marketing expenses decreased by  or sixteen percent from fiscal year a reduction in expenditures was responsible for eight percent of the decline while the strengthening of the dutch guilder contributed to the remainder of the decreased expenses between years 
the reduction in expense resulted principally from decreased commissions on export sales at clinical data australia and a decrease in the sales expenses at novachem bv 
research and development charges  as shown on the income statement  increased  or two percent from fiscal year during fiscal year  the company also spent an additional  which was capitalized on the consolidated balance sheet pursuant to the precepts of statement of financial accounting standards no 
see note n in the notes to consolidated financial statements 
general and administrative expenses decreased  or approximately fifteen percent from the similar period in fiscal year the reduction was the result of ongoing cost containment procedures implemented by the company  including decreased use of outside legal expense  coupled with the eight percent strengthening of the dutch guilder against the us dollar 
interest expense decreased for the annual period comparatives because of less reliance on the line of credit than in the prior year 
correspondingly  interest income declined as well because there were fewer funds available for investment 
other income and expense was basically the effect of foreign currency transaction gains and losses on the results of operations 
for fiscal and  minority interest is attributable to the six percent of vital scientific not held by the company 
the effect of foreign currency transaction exchange on the results of operations is included in other income expense and is not material to the financial statements 
see note in the notes to consolidated financial statements 
any impact on the company s liquidity is largely dependent on the exchange rates in effect at the time the predominant foreign functional currency  the dutch guilder  is translated into us dollars 
approximately  of the march  balance of  of cash  cash equivalents and marketable securities is denominated in us dollars 
the effect of translation into us dollars is reflected as a separate component of stockholders investment on the balance sheet 
the cumulative translation exchange adjustment in stockholders investment is approximately two percent of total assets on the march  consolidated balance sheet 
the effects of currency exchange rates on future quarterly or fiscal periods on the results of operations are difficult to estimate 
there are no formal hedging procedures employed by the company 
the primary risk is to monetary assets and liabilities denominated in currencies other than the us dollar 
approximately million of million of current assets reside in the company s foreign subsidiaries 

